Reflections on regulatory updates and industry recommendations for immunogenicity assessments: A CRO’s perspective
Deborah McManus and Gareth Satchell, Drug Development Solutions, LGC
Deborah McManus and Gareth Satchell, Drug Development Solutions, LGC
356-patient concordance study confirms performance using head-to-head testing vs. droplet digital PCR
ENPICOM will expand its IGX Platform to enable new liability analyses for antibody discovery workflows
Explore the intricacies of Alnylam Pharmaceuticals’ move from 9 crowded labs to a spacious research facility
Top talks presenting the latest technologies, research and applications are now available on demand
Real-world data demonstrated 92% vaccine effectiveness against hospitalisations due to the Delta variant
Integration expands automated, ultra-low volume dispensing capabilities across point-of-care diagnostics, clinical diagnostics and the life sciences, positioning customers for further growth
In a first, the digital fiber contains memory, temperature sensors, and a trained neural network program for inferring physical activity
The new solution promises to accelerate experimental success and improve process reliability as industry looks to faster drug discovery post-Covid-19
Infectious disease scientist Dr. Padmapriya Banada explores the potential of cycle threshold values and reveals her melt-based assay alternative